ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00190	Oxidative phosphorylation	74/171	127/7206	6.62207008716e-93
ko05012	Parkinson's disease	67/171	155/7206	1.10486015023e-71
ko05010	Alzheimer's disease	67/171	202/7206	2.55469087946e-62
ko05016	Huntington's disease	68/171	215/7206	1.05577509832e-61
ko04932	Non-alcoholic fatty liver disease (NAFLD)	58/171	182/7206	3.31168668815e-52
ko04723	Retrograde endocannabinoid signaling	37/171	175/7206	1.15298316419e-25
ko03010	Ribosome	25/171	129/7206	1.57134020337e-16
ko04260	Cardiac muscle contraction	17/171	98/7206	9.34300078044e-11
ko01200	Carbon metabolism	11/171	128/7206	0.000214305350377
ko00640	Propanoate metabolism	5/171	34/7206	0.00113041373871
ko00020	Citrate cycle (TCA cycle)	5/171	35/7206	0.00129383187702
ko00280	Valine, leucine and isoleucine degradation	6/171	54/7206	0.00164406048808
ko05200	Pathways in cancer	3/171	492/7206	0.00497568175665
ko04144	Endocytosis	1/171	342/7206	0.00514526715093
ko01210	2-Oxocarboxylic acid metabolism	3/171	20/7206	0.0111225079888
ko04015	Rap1 signaling pathway	1/171	278/7206	0.0150398944231
ko04014	Ras signaling pathway	1/171	279/7206	0.0150437728516
ko04120	Ubiquitin mediated proteolysis	8/171	138/7206	0.0166383969774
ko00627	Aminobenzoate degradation	2/171	9/7206	0.0180623048942
ko00071	Fatty acid degradation	4/171	45/7206	0.0214207696415
ko05205	Proteoglycans in cancer	1/171	271/7206	0.0223914037943
ko04966	Collecting duct acid secretion	3/171	26/7206	0.0228720145902
ko00010	Glycolysis / Gluconeogenesis	5/171	74/7206	0.0307095778678
ko04136	Autophagy - other	3/171	31/7206	0.0362945781759
ko04721	Synaptic vesicle cycle	5/171	80/7206	0.0409789783137
ko00062	Fatty acid elongation	3/171	33/7206	0.0425759688931
ko04530	Tight junction	1/171	228/7206	0.0452777966768